Table 4.
Fumonisins | Treatment | Experimental Period | Impacts/Chicken Type | Publication Date | References |
---|---|---|---|---|---|
Feed Efficiency and Growth Performance | 5 mg/kg | 22-d | Decrease in BWG/Broiler | 2001 | [45] |
50,200 mg/kg | 33-d | Decrease in BW and BWG/Broiler | 2006 | [49] | |
200 mg/kg | 33-d | Decrease in BW and BWG/Broiler | 2006 | [49] | |
100 mg/kg | 21-d | Increase in FCR/Broiler | 2014 | [153] | |
100 mg/kg | 28-d | Increase in FCR and decrease in FI and BW/Broiler | 2016 | [130] | |
Antioxidants status | 100 mg/kg | 21-d | Decrease in SOD, GST and NPSH | 2014 | [153] |
2.5, 5, or 10 ppm | 11-d | Increase in liver LPO and ROS; decrease in SOD, GPx, and GST activity; decrease in serum LPO levels and ROS levels/Broiler | 2020 | [154] | |
600 mg/kg | 15-d | Increase in TPA, ROS, and SOD; decrease in GPx/Broiler | 2020 | [155] | |
Blood Parameters | 25, 50 or 100 mg/kg | 8 -15-d | Increase in plasma ALT and AST, Ur and Cr/Broiler | 2017 | [156] |
2.5, 5, or 10 ppm | 11-d | Decrease in T.P, ALB, Glu, ALT, T.G and U.A/Broiler | 2020 | [154] | |
600 mg/kg | 15-d | Increase in Cho and decrease in U.A/Broiler | 2020 | [155] | |
0.05–20 ppm | 42-d | Increase in ALT, AST and U.A/Broiler | 2021 | [157] | |
Internal organs | 50 mg/kg | 22-d | Variations in hepatic histopathology/Broiler | 2006 | [49] |
200 mg/kg | 33-d | Increase liver weight and changes in hepatic histopathology/Broiler | 2006 | [49] | |
100 mg/kg | 28-d | Reduced villus height and the ratio of villus to crypt Variations in hepatic histopathology/Broiler | 2012 | [51] | |
100 mg/kg | 21-d | Increase liver absolut and relative weight/Broiler | 2014 | [153] |
BW = body weight; BWG = body weight gain; FI = feed intake; FCR = feed conversion ratio; SOD = superoxide dismutase; GST = glutathione S-transferase; NPSH = non-protein thiol; OS = reactive oxygen species; ALT = alanine aminotransferase; AST = aspartate aminotransferase; U.A = uric acid.